Premium
New molecular aspects of regulation of mitochondrial activity by fenofibrate and fasting
Author(s) -
Casas François,
Pineau Thierry,
Rochard Pierrick,
Rodier Anne,
Daury Laetitia,
Dauça Michel,
Cabello Gérard,
Wrutniak-Cabello Chantal
Publication year - 2000
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(00)02023-8
Subject(s) - fenofibrate , peroxisome , mitochondrion , organelle , peroxisome proliferator activated receptor , receptor , cytochrome c oxidase , citrate synthase , biology , lipid metabolism , western blot , endocrinology , medicine , chemistry , microbiology and biotechnology , enzyme , biochemistry , gene
Fenofibrate and fasting are known to regulate several genes involved in lipid metabolism in a similar way. In this study measuring several mitochondrial enzyme activities, we demonstrate that, in contrast to citrate synthase and complex II, cytochrome c oxidase (COX) is a specific target of these two treatments. In mouse liver organelles, Western blot experiments indicated that mitochondrial levels of p43, a mitochondrial T3 receptor, and mitochondrial peroxisome proliferator activated receptor (mt‐PPAR), previously described as a dimeric partner of p43 in the organelle, are increased by both fenofibrate and fasting. In addition, in PPARα‐deficient mice, this influence was abolished for mt‐PPAR but not for p43, whereas the increase in COX activity was not altered. These data indicate that: (1) PPARα is involved in specific regulation of mt‐PPAR expression by both treatments; (2) fenofibrate and fasting regulate the mitochondrial levels of p43 and thus affect the efficiency of the direct T3 mitochondrial pathway.